Immune and Metabolic Reprogramming Induced by Paclitaxel, Capecitabine and Eribulin in Breast Cancer: Insights into Therapeutic Targets is a research paper published in Breast Cancer Targets and Therapy (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCATS NIH HHS
Grant: R03 TR004607
NCATS NIH HHS
Grant: KL2 TR001413
NCI NIH HHS
Grant: K08 CA279766
National Institutes of Health
Grant: 1K08CA279766-01A1
Stress-induced immunosuppression via downregulation of interferon in triple negative breast cancer
National Institutes of Health
Grant: 3U24CA232979-01S1
Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCI
National Institutes of Health
Grant: 3UL1TR001412-08S3
Buffalo Clinical and Translational Research Center
National Institutes of Health
Grant: 3U24CA274159-03S1
Coordinating and Data Management Center for Acquired Resistance to Therapy Network
National Institutes of Health
Grant: 1R03TR004607-01
Identifying the role of interferon and interferon-regulated chemokines in stress-induced immunosuppression in triple negative breast cancer
National Institutes of Health
Grant: 5KL2TR001413-03
Buffalo Clinical and Translational Research Center
National Institutes of Health
Grant: 2R25CA203650-06
Transdisciplinary Research in Energetics and Cancer (TREC) Training Grant
FWCI
0.00
Citation Percentile
0.1%
Fields of Study
Keywords
Sustainable Development Goals